Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment

被引:155
作者
Cai, Fengfeng [1 ]
Luis, Manuel Antonio Falar [1 ]
Lin, Xiaoyan [1 ]
Wang, Minghong [2 ,3 ]
Cai, Lu [1 ]
Cen, Chunmei [1 ]
Biskup, Ewelina [4 ]
机构
[1] Tongji Univ, Sch Med, Yangpu Hosp, Dept Breast Surg, 450 Tengyue Rd, Shanghai 200090, Peoples R China
[2] Tongji Univ, Sch Med, Yangpu Hosp, Dept Gen Practice, 450 Tengyue Rd, Shanghai 200090, Peoples R China
[3] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Cardiol, Shanghai 200438, Peoples R China
[4] Shanghai Univ Med & Hlth Sci, Dept Basic Med Sci, Shanghai 201318, Peoples R China
基金
芬兰科学院; 上海市自然科学基金;
关键词
anthracyclines; breast cancer; doxorubicin; cardiotoxicity; risk factors; prevention; treatment; DOXORUBICIN-INDUCED CARDIOTOXICITY; CONGESTIVE-HEART-FAILURE; CARDIAC TROPONIN-T; CARDIOVASCULAR-DISEASE; MOLECULAR-BASIS; RISK-FACTORS; THERAPY; TOXICITY; ECHOCARDIOGRAPHY; INHIBITION;
D O I
10.3892/mco.2019.1854
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of malignancies. Cardiotoxicity is a well-recognized side effect of anthracycline therapy that limits the total amount of drug administered and can cause heart failure in some patients. Most experimental data support oxidative stress as the etiology of anthracycline-induced cardiotoxicity. The objective of this paper was to provide a review of the clinical classification, risk factors, monitoring and prevention of anthracycline-induced cardiotoxicity in patients with breast cancer.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 61 条
[1]   Role of N-Acetylcysteine and Coenzyme Q10 in the Amelioration of Myocardial Energy Expenditure and Oxidative Stress, Induced by Carbon Tetrachloride Intoxication in Rats [J].
Abd Elbaky, Nayira A. ;
El-Orabi, Naglaa F. ;
Fadda, Laila M. ;
Abd-Elkader, Omar H. ;
Ali, Hanaa M. .
DOSE-RESPONSE, 2018, 16 (03)
[2]   Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].
Albini, Adriana ;
Pennesi, Giuseppina ;
Donatelli, Francesco ;
Cammarota, Rosaria ;
De Flora, Silvio ;
Noonan, Douglas M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25
[3]   Present and future evolution of advanced breast cancer therapy [J].
Alvarez, Ricardo H. .
BREAST CANCER RESEARCH, 2010, 12
[4]  
Angelis AD, 2008, DOXORUBICIN CARDIOTO
[5]  
[Anonymous], 2016, SEER CANC STAT FACTS
[6]   LV Mass Assessed by Echocardiography and CMR, Cardiovascular Outcomes, and Medical Practice [J].
Armstrong, Anderson C. ;
Gidding, Samuel ;
Gjesdal, Ola ;
Wu, Colin ;
Bluemke, David A. ;
Lima, Joao A. C. .
JACC-CARDIOVASCULAR IMAGING, 2012, 5 (08) :837-848
[7]   Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis [J].
Baker, William L. ;
Anglade, Moise W. ;
Baker, Erica L. ;
White, Charles Michael ;
Kluger, Jeffrey ;
Coleman, Craig I. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (03) :521-527
[8]  
Cai F., 2015, J Oncol, V21, P1010
[9]   Epigenetic Therapy for Breast Cancer [J].
Cai, Feng-Feng ;
Kohler, Corina ;
Zhang, Bei ;
Wang, Ming-Hong ;
Chen, Wei-Jie ;
Zhong, Xiao-Yan .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (07) :4465-4476
[10]  
Canadian Cancer Society, 2016, CAN CANC SOC ADV COM